Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Claris Lifesciences

Sector: Healthcare | Industry: Drugs & Pharma
R 396.55 -0.25  | -0.06% 23.56% - 2,163.88
BSE Price: Mar 14, 2018 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Mar 14, 2018 396.55 -0.25 -0.06% 395.10 396.80 76,598 395.00 - 396.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 143,410 P/B: 0.74 NSE Code:
52-Week Range: R 308.00 - 425.70 Dividend Yield: 0.00% BSE Code: 533288
TTM EPS: R -1.37 Book Value: R 533.11 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Venmax Drugs And Pharmaceutica (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue - - -
Net Profit -148.14 -152.19 -
EPS -144.07 21.87 -
Book Value -1,005.03 -119.07 -
Average
Operating Margin - 45.79 37.80
Net Margin - 20.60 19.39
Return on Networth 0.00 5.69 6.66
Return on Investment 0.00 7.85 7.31
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -52.06 -54.56 -53.16
Operating Profit 41.59 380.66 1,171.30
Net Profit -117.25 -999.90 -883.02
EPS -117.25 -1,808.92 -958.76
TTM
Revenue -15.13 -46.32 14.99
Operating Profit 1,601.68 328.08 366.16
Net Profit -18.21 1,512.81 1,064.73
EPS -17.55 2,082.68 1,336.45
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Claris Lifesciences 2,163.88 13.92 1,584.22 38.83 0.00 0.74 -
Venmax Drugs And Pharmaceutica 2.19 0.25 -0.38 -150.60 0.00 -1.13 -
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 27, 2018 Suisse Finance (India) Pvt Ltd  Buy Encumbrance Share 52,276,684 392.15 205,003.02
Feb 23, 2018 Athanas Enterprise Pvt Ltd  Buy Delisting Offer 11,798,104 393.35 46,407.84
Feb 23, 2018 Athanas Enterprise Pvt Ltd & Claris Holdings Pvt Ltd  Buy Market 24,923,104 393.35 98,035.03
Oct 24, 2016 IDBI Trusteeship Services Ltd  Sell Released 6,250 297.05 18.57
Oct 19, 2016 IDBI Trusteeship Services Ltd  Sell Released 26,000 277.10 72.05
Fund Houses invested in the stock
Fund Dec-17 Sep-17 Jun-17 Mar-17 Dec-16
Nippon India Mutual Fund 1.932 1.932 1.860 1.860 1.493
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Claris Lifesciences Ltd.

Address: Claris Corporate Headquarters, Near Parimal Railway Crossing, Ellisbridge, Ahmedabad, Gujarat - 380006 | Phone: +91 79 26563331, 66309339 | Fax: +91 79 26408053

Email: [email protected]

Website: www.clarislifesciences.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
40.30
Piotroski F-Score
3
Modified C-Score
3
3-Years Price to Earnings
Not applicable
3-Years Price to Book
0.74
Earnings Yield
EBIT / Enterprise value
-0.22%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Venmax Drugs And Pharmaceutica R4.18 -0.71%
As on Mar 19, 2018